132 related articles for article (PubMed ID: 2475900)
1. Ambulatory infusion of bleomycin in patients receiving chemotherapy for germ cell tumors.
Green JA; Hammond P; Watkin SW
Sel Cancer Ther; 1989; 5(2):93-5. PubMed ID: 2475900
[No Abstract] [Full Text] [Related]
2. Reassessment of 4-Cycle Etoposide and Cisplatin as the Standard of Care for Good-Risk Metastatic Germ Cell Tumors.
Fein DE; Paulus JK; Mathew P
JAMA Oncol; 2018 Dec; 4(12):1661-1662. PubMed ID: 30325997
[No Abstract] [Full Text] [Related]
3. Ovarian germ cell malignancies: the Yale University experience.
Schwartz PE; Chambers SK; Chambers JT; Kohorn E; McIntosh S
Gynecol Oncol; 1992 Apr; 45(1):26-31. PubMed ID: 1376294
[No Abstract] [Full Text] [Related]
4. Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?
Einhorn LH; Foster RS
J Clin Oncol; 2006 Jun; 24(16):2597-8; author reply 2598-9. PubMed ID: 16735718
[No Abstract] [Full Text] [Related]
5. A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3).
Shamash J; Sarker SJ; Huddart R; Harland S; Joffe JK; Mazhar D; Birtle A; White J; Chowdhury K; Wilson P; Marshall MR; Vinnicombe S
Ann Oncol; 2017 Jun; 28(6):1333-1338. PubMed ID: 28327896
[TBL] [Abstract][Full Text] [Related]
6. Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
Culine S; Théodore C; Bekradda M; Farhat F; Terrier-Lacombe MJ; Droz JP
Am J Clin Oncol; 1997 Apr; 20(2):184-8. PubMed ID: 9124197
[TBL] [Abstract][Full Text] [Related]
7. High-risk germ cell tumors in men. High response rate and severe toxicity with cisplatin, vinblastine, bleomycin, and etoposide.
Blayney DW; Goldberg DA; Leong LA; Margolin KA; Burke JS; Doroshow JH
Cancer; 1993 Apr; 71(7):2351-7. PubMed ID: 7680946
[TBL] [Abstract][Full Text] [Related]
8. Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution.
Germá JR; Sagarra AF; Izquierdo MA; Seguí MA
Cancer; 1993 Feb; 71(3):796-803. PubMed ID: 7679314
[TBL] [Abstract][Full Text] [Related]
9. Bilateral Lung Transplantation for Bleomycin-Associated Lung Injury.
Narayan V; Deshpande C; Bermudez CA; Golato JM; Lee JC; Diamond J; Vaughn DJ
Oncologist; 2017 May; 22(5):620-622. PubMed ID: 28360217
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study.
Curigliano G; Spitaleri G; Magni E; Lorizzo K; De Cobelli O; Locatelli M; Fumagalli L; Adamoli L; Cossu Rocca M; Verri E; De Pas T; Jereczek-Fossa B; Martinelli G; Goldhirsch A; Nolè F
J Chemother; 2009 Dec; 21(6):687-92. PubMed ID: 20071294
[TBL] [Abstract][Full Text] [Related]
11. Systemic thromboembolism after anti-cancer chemotherapy in a woman with ovarian germ cell tumor.
Yanazume S; Tsuji T; Matsuo T; Kamio M; Terao S; Douchi T
J Obstet Gynaecol Res; 2013 Mar; 39(3):742-5. PubMed ID: 23148694
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of Clostridium difficile diarrhoea during intensive chemotherapy for disseminated germ cell cancer.
Nielsen H; Daugaard G; Tvede M; Bruun B
Br J Cancer; 1992 Oct; 66(4):666-7. PubMed ID: 1384640
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors.
Maruyama Y; Sadahira T; Mitsui Y; Araki M; Wada K; Tanimoto R; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
Med Oncol; 2018 Apr; 35(6):80. PubMed ID: 29700638
[TBL] [Abstract][Full Text] [Related]
14. Cerebrovascular accident after chemotherapy for testicular cancer.
Karagoz B; Bilgi O; Akyol I; Ozgun A; Turken O; Kandemir EG
Mil Med; 2009 Mar; 174(3):320-1. PubMed ID: 19354100
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
[TBL] [Abstract][Full Text] [Related]
16. [Germ cell tumors].
Murakawa Y
Nihon Rinsho; 2015 Feb; 73 Suppl 2():614-7. PubMed ID: 25831833
[No Abstract] [Full Text] [Related]
17. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
18. Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.
Brada M; Horwich A; Peckham MJ
Cancer Treat Rep; 1987 Jun; 71(6):655-6. PubMed ID: 2438041
[TBL] [Abstract][Full Text] [Related]
19. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
Peckham MJ; Barrett A; Liew KH; Horwich A; Robinson B; Dobbs HJ; McElwain TJ; Hendry WF
Br J Cancer; 1983 May; 47(5):613-9. PubMed ID: 6189504
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
